Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT01818882
Other study ID # LOCAL/2012/XB-01
Secondary ID 2013-A00100-45
Status Terminated
Phase N/A
First received March 23, 2013
Last updated April 5, 2016
Start date April 2014
Est. completion date January 2016

Study information

Verified date March 2016
Source Centre Hospitalier Universitaire de Nimes
Contact n/a
Is FDA regulated No
Health authority France: Committee for the Protection of PersonnesFrance: Agence Nationale de Sécurité du Médicament et des produits de santé
Study type Interventional

Clinical Trial Summary

The main objective of our study is to compare the effects of two care strategies for dyspneic patients on the length of hospital stay: (1) standard care (=contextual analysis + conventional clinical chest radiography) versus (2) standard care + pleuropulmonary ultrasound.


Description:

The secondary objectives of this study are to assess the following for both arms:

A-fatality rate, B-degree of concordance between the diagnosis orientation in the emergency department and final diagnosis determined by an expert committee using patient records one month later (blind evaluation by a panel of experts) C-clinical improvement between early emergency care and later care outside the emergency department (clinical parameters = blood gases and other biological parameters) D-imaging parameters.


Recruitment information / eligibility

Status Terminated
Enrollment 85
Est. completion date January 2016
Est. primary completion date January 2016
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- The patient must have given his/her informed and signed consent

- The patient must be insured or beneficiary of a health insurance plan

- Patient consulting in the emergency department for dyspnea

Exclusion Criteria:

- The patient is participating in another study

- The patient is in an exclusion period determined by a previous study

- The patient is under judicial protection, under tutorship or curatorship

- The patient refuses to sign the consent

- It is impossible to correctly inform the patient

- The patient cannot read French

- The patient is pregnant, parturient, or breastfeeding

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention


Related Conditions & MeSH terms


Intervention

Other:
Standard care
Standard care for dyspneic patients including contextual analysis, conventional clinical exam and a chest X-Ray.
Device:
Vscan portable ultrasound device (GE Healthcare, Wauwatosa, WI)
Standard care (as described for the other intervention) + pleuropulmonary ultrasound using the Vscan portable ultrasound device (GE Healthcare, Wauwatosa, WI).

Locations

Country Name City State
France CHU de Nîmes - Hôpital Universitaire Carémeau Nîmes Cedex 9

Sponsors (1)

Lead Sponsor Collaborator
Centre Hospitalier Universitaire de Nimes

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Length of hospital stay in days 1 month Yes
Secondary Patient deceased? yes/no 1 month Yes
Secondary Diagnosis in the emergency room upon discharge from the emergency department (max 1 month) No
Secondary Diagnosis given by expert committee based on patient file 1 month No
Secondary Glasgow scale Baseline, day 0 No
Secondary Glasgow scale day 3 No
Secondary Heart rate baseline, day 0 No
Secondary Heart rate day 3 No
Secondary Respiratory rate baseline, day 0 No
Secondary Respiratory rate day 3 No
Secondary Systolic blood pressure baseline, day 0 No
Secondary Systolic blood pressure day 3 No
Secondary Diastolic blood pressure baseline, day 0 No
Secondary Diastolic blood pressure day 3 No
Secondary Temperature baseline, day 0 No
Secondary Temperature day 3 No
Secondary blood pH baseline, day 0 No
Secondary blood pH day 3 No
Secondary CO2 arterial pressure baseline, day 0 No
Secondary CO2 arterial pressure day 3 No
Secondary O2 arterial pressure baseline, day 0 No
Secondary O2 arterial pressure day 3 No
Secondary O2 saturation baseline, day 0 No
Secondary O2 saturation day 3 No
Secondary Alkaline reserve baseline, day 0 No
Secondary Alkaline reserve day 3 No
Secondary white blood cell count baseline, day 0 No
Secondary white blood cell count day 3 No
Secondary C-reactive protein baseline, day 0 No
Secondary C-reactive protein day 3 No
Secondary Brain Natriuretic Peptide baseline, day 0 No
Secondary Brain Natriuretic Peptide day 3 No
Secondary hemoglobin baseline, day 0 No
Secondary hemoglobin day 3 No
Secondary Pulmonary x-ray, yes/no baseline, day 0 No
Secondary right alveolar opacities on x-ray, yes/no baseline, day 0 No
Secondary left alveolar opacities on x-ray, yes/no baseline, day 0 No
Secondary right parenchymal origin on x-ray, yes/no baseline, day 0 No
Secondary left parenchymal origin on x-ray, yes/no baseline, day 0 No
Secondary right pleural effusion on x-ray, yes/no baseline, day 0 No
Secondary left pleural effusion on x-ray, yes/no baseline, day 0 No
Secondary pleuropulmonary ultrasound, yes/no baseline, day 0 No
Secondary right alveolar-interstitial syndrome on ultrasound, yes/no baseline, day 0 No
Secondary left alveolar-interstitial syndrome on ultrasound, yes/no baseline, day 0 No
Secondary right lung consolidation on ultrasound, yes/no baseline, day 0 No
Secondary left lung consolidation on ultrasound, yes/no baseline, day 0 No
Secondary right pleural effusion on ultrasound, yes/no baseline, day 0 No
Secondary left pleural effusion on ultrasound, yes/no baseline, day 0 No
Secondary right pneumothorax on ultrasound, yes/no baseline, day 0 No
Secondary left pneumothorax on ultrasound, yes/no baseline, day 0 No
See also
  Status Clinical Trial Phase
Active, not recruiting NCT04688905 - Diagnosing Heart Failure With Preserved Ejection Fraction in Patients With Unexplained Dyspnea (Diagnose-HFpEF)
Completed NCT03679312 - The Effect of Inhaled Nitric Oxide on Dyspnea and Exercise Tolerance in COPD Phase 1/Phase 2
Recruiting NCT04868357 - Hypnosis for the Management of Anxiety and Breathlessness During a Pulmonary Rehabilitation Program N/A
Active, not recruiting NCT03604822 - Music Therapy Protocol to Support Bulbar and Respiratory Functions in ALS N/A
Completed NCT03626519 - Effects of Menthol on Dyspnoea in COPD Patients N/A
Completed NCT02638649 - Prehospital Use of Ultrasound in Undifferentiated Shortness of Breath
Terminated NCT02269761 - Chest Ultrasound of ER Patients With Cough or SOB
Completed NCT02248831 - Evaluation of Cardiopulmonary Diseases by Ultrasound N/A
Completed NCT02538770 - Rapid Viral Diagnostics in Adults to Reduce Antimicrobial Consumption and Duration of Hospitalization N/A
Recruiting NCT01655199 - Sensitivity of the Step Test to Detect Improvement in Dyspnea Following Bronchodilation in Patients With Chronic Obstructive Pulmonary Disease N/A
Active, not recruiting NCT01440764 - Aerosol Inhalation Treatment for Dyspnea Phase 1/Phase 2
Completed NCT01577407 - Non Opioid Treatment for Experimental Dyspnea Phase 3
Completed NCT01193998 - Impact of Validated Diagnostic Prediction Model of Acute Heart Failure in the Emergency Department N/A
Recruiting NCT04327882 - Point-of-care Ultrasound Interest in Dyspneic Emergency Department Patients: an Observational Bicentric Study
Completed NCT05029986 - Preventing Dyspnea During Speech in Older Speakers N/A
Not yet recruiting NCT04181359 - The Effect of Inhaled Nitric Oxide on Dyspnea and Exercise Tolerance in Interstitial Lung Disease. Phase 1/Phase 2
Recruiting NCT04615065 - Acutelines: a Large Data-/Biobank of Acute and Emergency Medicine
Completed NCT04305639 - The Reliability and Validity of Turkish Version of ''The Dyspnea-ALS-Scale (DALS-15)"
Completed NCT04370990 - Automated Oxygen Administration -Rethinking Interventions Alleviating Dyspnea in Patients With COPD N/A
Completed NCT04375917 - Is Reduced Hypoxia Through a Robot Intervention, Associated With Sensory and Emotional Descriptions of Dyspnea, Anxiety, Depression, Symptom Burden and Anxiolytics N/A